Raphaël de Coninck will be speaking at a seminar on recent antitrust developments in the pharmaceutical sector. Details are available here.
Assessing umbrella pricing incentives
When collusive agreements involve a subset of firms in an industry, they may create the incentive and ability for firms that are not participants in the cartel...